Literature DB >> 26876382

Pharmacological Manipulation of the Rostromedial Tegmental Nucleus Changes Voluntary and Operant Ethanol Self-Administration in Rats.

Rao Fu1, Wanhong Zuo1, Danielle Gregor1, Jing Li1, Dennis Grech1, Jiang-Hong Ye1.   

Abstract

BACKGROUND: The aversive properties of ethanol (EtOH) that limit its intake are poorly understood. There is an increasing interest in the role of the rostromedial tegmental nucleus (RMTg), because it encodes aversion signals and inhibits motivated behaviors. It is also a major source of inhibitory GABAergic inputs to the midbrain dopamine neurons. Up to this time, the role of the RMTg in EtOH-drinking behaviors has not been well explored.
METHODS: Male Long-Evans rats were trained either to drink EtOH under the intermittent 2-bottle-choice protocol or to self-administer EtOH in operant chambers under fixed-ratio-3 schedules. Changes in drinking behaviors induced by the bilateral infusion into the RMTg of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), an agonist of AMPA-type glutamate receptors, or muscimol, an agonist of GABAA receptors, were measured.
RESULTS: Consumption and preference for EtOH, numbers of active lever pressing, and head entrance to the EtOH port were all significantly decreased upon activation of the RMTg by the infusion of AMPA, but were increased upon inhibition of the RMTg by the infusion of muscimol. By contrast, intra-RMTg infusion of these agents did not change sucrose consumption.
CONCLUSIONS: These data show for the first time that EtOH-drinking and EtOH-seeking behaviors of rats changed inversely with RMTg function, supporting the idea that the RMTg plays a crucial role in EtOH-drinking behaviors.
Copyright © 2016 by the Research Society on Alcoholism.

Entities:  

Keywords:  Microinjection; Muscimol; Stereotaxic Surgery; α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid

Mesh:

Substances:

Year:  2016        PMID: 26876382      PMCID: PMC4775316          DOI: 10.1111/acer.12974

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  37 in total

1.  Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens.

Authors:  S M Nicola; R C Malenka
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Negative reward signals from the lateral habenula to dopamine neurons are mediated by rostromedial tegmental nucleus in primates.

Authors:  Simon Hong; Thomas C Jhou; Mitchell Smith; Kadharbatcha S Saleem; Okihide Hikosaka
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

3.  The rostromedial tegmental nucleus modulates behavioral inhibition following cocaine self-administration in rats.

Authors:  Mary L Huff; Ryan T LaLumiere
Journal:  Neuropsychopharmacology       Date:  2014-09-26       Impact factor: 7.853

4.  Blockade of GABA(A) receptors in the paraventricular nucleus of the hypothalamus attenuates voluntary ethanol intake and activates the hypothalamic-pituitary-adrenocortical axis.

Authors:  Jing Li; Weiliang Bian; Vaidehi Dave; Jiang-Hong Ye
Journal:  Addict Biol       Date:  2011-07-18       Impact factor: 4.280

5.  The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta.

Authors:  Thomas C Jhou; Stefanie Geisler; Michela Marinelli; Beth A Degarmo; Daniel S Zahm
Journal:  J Comp Neurol       Date:  2009-04-20       Impact factor: 3.215

6.  Representation of negative motivational value in the primate lateral habenula.

Authors:  Masayuki Matsumoto; Okihide Hikosaka
Journal:  Nat Neurosci       Date:  2008-11-30       Impact factor: 24.884

7.  The influence of DeltaFosB in the nucleus accumbens on natural reward-related behavior.

Authors:  Deanna L Wallace; Vincent Vialou; Loretta Rios; Tiffany L Carle-Florence; Sumana Chakravarty; Arvind Kumar; Danielle L Graham; Thomas A Green; Anne Kirk; Sergio D Iñiguez; Linda I Perrotti; Michel Barrot; Ralph J DiLeone; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2008-10-08       Impact factor: 6.167

Review 8.  Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse.

Authors:  Sebastien Carnicella; Dorit Ron; Segev Barak
Journal:  Alcohol       Date:  2014-03-15       Impact factor: 2.405

9.  Understanding how opioids contribute to reward and analgesia.

Authors:  Howard L Fields
Journal:  Reg Anesth Pain Med       Date:  2007 May-Jun       Impact factor: 6.288

10.  Lesions of the lateral habenula increase voluntary ethanol consumption and operant self-administration, block yohimbine-induced reinstatement of ethanol seeking, and attenuate ethanol-induced conditioned taste aversion.

Authors:  Andrew K Haack; Chandni Sheth; Andrea L Schwager; Michael S Sinclair; Shashank Tandon; Sharif A Taha
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

View more
  13 in total

Review 1.  Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.

Authors:  Sunil Goodwani; Hannah Saternos; Fawaz Alasmari; Youssef Sari
Journal:  Neurosci Biobehav Rev       Date:  2017-02-24       Impact factor: 8.989

2.  Alcohol withdrawal drives depressive behaviors by activating neurons in the rostromedial tegmental nucleus.

Authors:  Rao Fu; Wanhong Zuo; Nimisha Shiwalkar; Qinghua Mei; Qing Fan; Xuejun Chen; Jing Li; Alex Bekker; Jiang-Hong Ye
Journal:  Neuropsychopharmacology       Date:  2019-03-31       Impact factor: 7.853

3.  Withdrawal from Chronic Nicotine Exposure Produces Region-Specific Tolerance to Alcohol-Stimulated GluA1 Phosphorylation.

Authors:  M Adrienne McGinn; Rod I Paulsen; Christy A Itoga; Muhammad A Farooq; Jonathan E Reppel; Kimberly N Edwards; Annie M Whitaker; Nicholas W Gilpin; Scott Edwards
Journal:  Alcohol Clin Exp Res       Date:  2016-10-31       Impact factor: 3.455

4.  Activation of glycine receptors in the lateral habenula rescues anxiety- and depression-like behaviors associated with alcohol withdrawal and reduces alcohol intake in rats.

Authors:  Wenting Li; Wanhong Zuo; Wei Wu; Qi Kang Zuo; Rao Fu; Liangzhi Wu; Haifeng Zhang; Michael Ndukwe; Jiang-Hong Ye
Journal:  Neuropharmacology       Date:  2019-06-27       Impact factor: 5.250

5.  Activation of locus coeruleus to rostromedial tegmental nucleus (RMTg) noradrenergic pathway blunts binge-like ethanol drinking and induces aversive responses in mice.

Authors:  Ana Paula S Dornellas; Nathan W Burnham; Kendall L Luhn; Maxwell V Petruzzi; Todd E Thiele; Montserrat Navarro
Journal:  Neuropharmacology       Date:  2021-09-20       Impact factor: 5.250

Review 6.  The rostromedial tegmental (RMTg) "brake" on dopamine and behavior: A decade of progress but also much unfinished work.

Authors:  Thomas C Jhou
Journal:  Neuropharmacology       Date:  2021-08-22       Impact factor: 5.273

7.  Inhibition of AMPA receptor and CaMKII activity in the lateral habenula reduces depressive-like behavior and alcohol intake in rats.

Authors:  Jing Li; Seungwoo Kang; Rao Fu; Liangzhi Wu; Wei Wu; Hongwei Liu; Danielle Gregor; Wanhong Zuo; Alex Bekker; Jiang-Hong Ye
Journal:  Neuropharmacology       Date:  2017-08-31       Impact factor: 5.250

8.  Low-dose ethanol excites lateral habenula neurons projecting to VTA, RMTg, and raphe.

Authors:  Rao Fu; Qinghua Mei; Wanhong Zuo; Jing Li; Danielle Gregor; Alex Bekker; Jianghong Ye
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-12-25

9.  Role for the Rostromedial Tegmental Nucleus in Signaling the Aversive Properties of Alcohol.

Authors:  Elizabeth J Glover; Molly J McDougle; Griffin S Siegel; Thomas C Jhou; L Judson Chandler
Journal:  Alcohol Clin Exp Res       Date:  2016-07-08       Impact factor: 3.455

10.  Prelimbic cortical projections to rostromedial tegmental nucleus play a suppressive role in cue-induced reinstatement of cocaine seeking.

Authors:  Adelis M Cruz; Haley F Spencer; Tabitha H Kim; Thomas C Jhou; Rachel J Smith
Journal:  Neuropsychopharmacology       Date:  2020-11-23       Impact factor: 8.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.